J. Ainsworth

发表

Proton MR Spectroscopy of the Brain in AIDS Dementia Complex

D. Menon, J. Ainsworth, I. Cox, 1992, Journal of computer assisted tomography.

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

M. García-Fiñana, R. Kolamunnage-Dona, C. Leen, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy.

Delpech, B. Gazzard, C. Leen, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

B. Gazzard, C. Leen, C. Sabin, 2011, BMJ : British Medical Journal.

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

D. Richman, A. Phillips, J. Ainsworth, 2015, EBioMedicine.

Antibodies to Mycoplasma penetrans in HIV-infected patients

J. Ainsworth, D. Taylor-Robinson, H. Alter, 1993, The Lancet.

Mycoplasma fermentans and HIV-associated nephropathy.

V. Cattell, J. Ainsworth, D. Taylor-Robinson, 1994, The Journal of infection.

Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study

B. Gazzard, C. Leen, D. Pillay, 2009, Journal of acquired immune deficiency syndromes.

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2022, Kidney international reports.

Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2021, Kidney international reports.

Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?

S. Lawn, R. Miller, J. Ainsworth, 2006, The Journal of infectious diseases.

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

B. Gazzard, I. Williams, A. Winston, 2012, JAMA.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Factors influencing lopinavir and atazanavir plasma concentration.

B. Gazzard, C. Leen, D. Pillay, 2010, The Journal of antimicrobial chemotherapy.

Virological response to initial antiretroviral regimens containing abacavir or tenofovir.

B. Gazzard, C. Leen, D. Pillay, 2009, The Journal of infectious diseases.

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

A. Mocroft, O. Kirk, J. González, 2021, BMC Infectious Diseases.

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.

R. Miller, J. Ainsworth, C. Smith, 2006, The Journal of infectious diseases.

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

B. Gazzard, C. Leen, C. Sabin, 2009, AIDS.

Changes in urate metabolism after castration of patients suffering from carcinoma of the prostate.

E. Warburton, J. Ainsworth, L. Darlington, 1991, Advances in experimental medicine and biology.

Imported HIV infection acquired heterosexually.

J. Ainsworth, J. Harris, S. Murphy, 1991, British medical journal.

HIV‐associated central nervous system diseases in the recent combination antiretroviral therapy era

B. Gazzard, C. Leen, D. Pillay, 2011, European journal of neurology.

High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.

D. Webster, M. Johnson, J. Ainsworth, 2014, AIDS.

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia

C. Leen, M. Pirmohamed, L. Haddow, 2016, Journal of NeuroVirology.

Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg.

J. Ainsworth, A. Owen, Stephen Taylor, 2012, The Journal of antimicrobial chemotherapy.

Factors Influencing Efavirenz and Nevirapine Plasma Concentration: Effect of Ethnicity, Weight and Co-Medication

C. Leen, D. Pillay, A. Winston, 2008, Antiviral therapy.

Disseminated pneumocystis carinii infection in AIDS.

R. Miller, J. Ainsworth, R. Coker, 1991, Journal of clinical pathology.

An association of disseminated Mycoplasma fermentans in HIV-1 positive patients with non-Hodgkin's lymphoma

P. Easterbrook, J. Ainsworth, D. Taylor-Robinson, 2001, International journal of STD & AIDS.

Disseminated Mycoplasma fermentans in AIDS patients: several case reports

J. Ainsworth, D. Taylor-Robinson, R. Goldin, 2000, International journal of STD & AIDS.

Detection of Mycoplasma fermentans in healthy students and patients with congenital immunodeficiency.

J. Ainsworth, D. Taylor-Robinson, A. Webster, 2000, The Journal of infection.

Mycoplasma Species in Rapid and Slow HIV Progressors

P. Easterbrook, J. Weber, J. Ainsworth, 2000 .

Novel Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase

J. Ainsworth, S. Malik, T. Pattery, 2007, Antimicrobial Agents and Chemotherapy.

Predicting virological decay in patients starting combination antiretroviral therapy

J. Sterne, C. Leen, R. Gilson, 2016, AIDS.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression

C. Leen, C. Sabin, A. Phillips, 2014, AIDS.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Kholoud Porter, John Walsh, Martin Fisher, 2014, AIDS.

Antiretroviral therapy for HIV-2 infected patients.

J. Oxford, R. Tedder, J. Ainsworth, 2001, The Journal of infection.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

C. Leen, D. Pillay, R. Gilson, 2017, The lancet. HIV.

Long‐term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study

C. Leen, D. Pillay, P. Easterbrook, 2011, HIV medicine.

Radiological and Histological Features of Intracerebral Cryptococcomata

J. Ainsworth, R. Coker, J. Harris, 1992, International journal of STD & AIDS.

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study

C. Leen, D. Pillay, C. Sabin, 2018, The lancet. HIV.

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

C. Leen, D. Pillay, R. Gilson, 2014, The Journal of infectious diseases.

Development and application of a new measure of engagement in out‐patient HIV care

B. Gazzard, C. Leen, D. Pillay, 2016, HIV Medicine.

The posterior reversible encephalopathy syndrome in HIV infection

J. Ainsworth, S. Nightingale, C. Wood, 2012, BMJ Case Reports.

Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors

Sabine Yerly, Ian Williams, Jonathan Ainsworth, 2011, PloS one.

Predictors of renal outcome in HIV-associated nephropathy.

P. Easterbrook, B. Hendry, J. Ainsworth, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK

J. Nazroo, A. Sullivan, J. Ainsworth, 2008, AIDS.

Uptake and Outcome of Combination Antiretroviral Therapy in Men Who Have Sex with Men According to Ethnic Group: The UK CHIC Study

B. Gazzard, C. Leen, C. Sabin, 2011, Journal of acquired immune deficiency syndromes.

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations *

C. Leen, C. Sabin, P. Easterbrook, 2010, HIV medicine.

Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity

L. Haddow, J. Ainsworth, C. Wood, 2007, International journal of STD & AIDS.

Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease

B. Gazzard, C. Leen, D. Pillay, 2011, Neurology.

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF☆

C. Leen, M. Pirmohamed, L. Haddow, 2016, Cytokine.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

B. Gazzard, D. Webster, C. Leen, 2015, HIV medicine.

Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?

B. Gazzard, C. Leen, D. Pillay, 2012, The Journal of infectious diseases.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

Non‐uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK

B. Gazzard, C. Leen, J. Ainsworth, 2012, HIV medicine.

Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment

A. Winston, J. Ainsworth, J. Day, 2014, PloS one.

1H MR Spectroscopy of the Brain in HIV-1-Seropositive Subjects: Evidence for Diffuse Metabolic Abnormalities

P. Easterbrook, S. Taylor-Robinson, J. Ainsworth, 1998, Metabolic Brain Disease.

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV

B. Gazzard, C. Leen, D. Pillay, 2018, The Journal of infectious diseases.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

A. Mocroft, O. Kirk, A. Schultze, 2018, The Journal of infection.

Factors influencing lopinavir and atazanavir plasma concentration.

B. Gazzard, C. Leen, D. Pillay, 2010, The Journal of antimicrobial chemotherapy.

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF☆

C. Leen, M. Pirmohamed, L. Haddow, 2016, Cytokine.

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

Andrew L. Kerr, C. Leen, C. Fraser, 2020, HIV medicine.